NCT06472830View on ClinicalTrials.gov

Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) / Multiple Myeloma (MM) Among Unique Populations of Black People

Enrolling by invitationOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 22, 2024

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
Monoclonal Gammopathy of Undetermined Significance
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06472830 - Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) / Multiple Myeloma (MM) Among Unique Populations of Black People | Biotech Hunter | Biotech Hunter